Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Honoraria | $3,840 | 1 | 75.0% |
| Travel and Lodging | $979.23 | 7 | 19.1% |
| Food and Beverage | $264.96 | 8 | 5.2% |
| Education | $35.82 | 3 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Global Blood Therapeutics, Inc. | $4,966 | 12 | $0 (2022) |
| Spark Therapeutics, Inc. | $55.53 | 1 | $0 (2023) |
| BioMarin Pharmaceutical Inc. | $49.45 | 2 | $0 (2024) |
| PFIZER INC. | $49.09 | 4 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $24.15 | 1 | BioMarin Pharmaceutical Inc. ($24.15) |
| 2023 | $94.10 | 3 | Spark Therapeutics, Inc. ($55.53) |
| 2022 | $4,966 | 12 | Global Blood Therapeutics, Inc. ($4,966) |
| 2020 | $35.82 | 3 | PFIZER INC. ($35.82) |
All Payment Transactions
19 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/13/2024 | BioMarin Pharmaceutical Inc. | ROCTAVIAN (Drug) | Food and Beverage | In-kind items and services | $24.15 | General |
| Category: Hemophilia A | ||||||
| 06/26/2023 | PFIZER INC. | OXBRYTA (Drug) | Food and Beverage | In-kind items and services | $13.27 | General |
| Category: HEMATOLOGY | ||||||
| 03/10/2023 | BioMarin Pharmaceutical Inc. | — | Food and Beverage | In-kind items and services | $25.30 | General |
| 03/09/2023 | Spark Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $55.53 | General |
| 09/12/2022 | Global Blood Therapeutics, Inc. | OXBRYTA (Drug) | Travel and Lodging | Cash or cash equivalent | $49.78 | General |
| Category: Sickle Cell Disease | ||||||
| 09/12/2022 | Global Blood Therapeutics, Inc. | OXBRYTA (Drug) | Travel and Lodging | Cash or cash equivalent | $47.88 | General |
| Category: Sickle Cell Disease | ||||||
| 09/12/2022 | Global Blood Therapeutics, Inc. | OXBRYTA (Drug) | Travel and Lodging | Cash or cash equivalent | $36.23 | General |
| Category: Sickle Cell Disease | ||||||
| 09/12/2022 | Global Blood Therapeutics, Inc. | OXBRYTA (Drug) | Travel and Lodging | Cash or cash equivalent | $31.12 | General |
| Category: Sickle Cell Disease | ||||||
| 09/12/2022 | Global Blood Therapeutics, Inc. | OXBRYTA (Drug) | Travel and Lodging | Cash or cash equivalent | $20.93 | General |
| Category: Sickle Cell Disease | ||||||
| 09/12/2022 | Global Blood Therapeutics, Inc. | OXBRYTA (Drug) | Food and Beverage | In-kind items and services | $14.81 | General |
| Category: Sickle Cell Disease | ||||||
| 08/25/2022 | Global Blood Therapeutics, Inc. | OXBRYTA (Drug) | Honoraria | Cash or cash equivalent | $3,840.00 | General |
| Category: Sickle Cell Disease | ||||||
| 08/17/2022 | Global Blood Therapeutics, Inc. | OXBRYTA (Drug) | Travel and Lodging | In-kind items and services | $326.16 | General |
| Category: Sickle Cell Disease | ||||||
| 08/16/2022 | Global Blood Therapeutics, Inc. | OXBRYTA (Drug) | Food and Beverage | In-kind items and services | $124.76 | General |
| Category: Sickle Cell Disease | ||||||
| 08/11/2022 | Global Blood Therapeutics, Inc. | OXBRYTA (Drug) | Travel and Lodging | In-kind items and services | $467.13 | General |
| Category: Sickle Cell Disease | ||||||
| 05/27/2022 | Global Blood Therapeutics, Inc. | OXBRYTA (Drug) | Food and Beverage | In-kind items and services | $2.36 | General |
| Category: Sickle Cell Disease | ||||||
| 04/21/2022 | Global Blood Therapeutics, Inc. | OXBRYTA (Drug) | Food and Beverage | In-kind items and services | $4.78 | General |
| Category: Sickle Cell Disease | ||||||
| 11/02/2020 | PFIZER INC. | BENEFIX (Biological) | Education | In-kind items and services | $13.25 | General |
| Category: HEMATOLOGY | ||||||
| 11/02/2020 | PFIZER INC. | BENEFIX (Biological) | Education | In-kind items and services | $11.33 | General |
| Category: HEMATOLOGY | ||||||
| 11/02/2020 | PFIZER INC. | BENEFIX (Biological) | Education | In-kind items and services | $11.24 | General |
| Category: HEMATOLOGY | ||||||
About Dr. Michael White, MD
Dr. Michael White, MD is a Pediatric Hematology-Oncology healthcare provider based in Atlanta, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/09/2013. The National Provider Identifier (NPI) number assigned to this provider is 1871936823.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael White, MD has received a total of $5,120 in payments from pharmaceutical and medical device companies, with $24.15 received in 2024. These payments were reported across 19 transactions from 4 companies. The most common payment nature is "Honoraria" ($3,840).
Practice Information
- Specialty Pediatric Hematology-Oncology
- Location Atlanta, GA
- Active Since 04/09/2013
- Last Updated 06/06/2022
- Taxonomy Code 2080P0207X
- Entity Type Individual
- NPI Number 1871936823
Products in Payments
- OXBRYTA (Drug) $4,979
- BENEFIX (Biological) $35.82
- ROCTAVIAN (Drug) $24.15
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pediatric Hematology-Oncology Doctors in Atlanta
Robert Sidonio, Md, MD
Pediatric Hematology-Oncology — Payments: $898,589
Shannon Meeks, Md, MD
Pediatric Hematology-Oncology — Payments: $366,833
Bhavya Doshi, M.d, M.D
Pediatric Hematology-Oncology — Payments: $177,468
Vivien Sheehan, Md, MD
Pediatric Hematology-Oncology — Payments: $100,331
Muna Qayed, Md, MD
Pediatric Hematology-Oncology — Payments: $76,871
Carlton Dampier, Md, MD
Pediatric Hematology-Oncology — Payments: $72,327